biomed Lab aims to raise the clinical value of laboratory medicine. In transfusion medicine, diagnostic hematology, molecular genetics and diagnostic immunology, we study quantitatively how test results lead to clinical decisions, and we evaluate the clinical applicability and safety of new diagnostic workflows.
Transfusion medicine / blood bank
We work on red cell antigen and antibody identification, analysis of incompatible transfusion reaction cases, and evaluation of the safety and appropriate use of blood products. The goal is better test protocols that bear directly on clinical decisions.
Diagnostic hematology
By interpreting peripheral blood and bone marrow morphology, flow cytometry and coagulation results together, we study diagnostic accuracy and standardized reporting for blood diseases. This includes validation of automated instruments and digital morphology.
Molecular genetic diagnostics
For hematologic malignancies, infectious diseases and hereditary disorders, we evaluate molecular testing workflows such as NGS, digital PCR and fusion gene detection, along with clinically usable variant interpretation and reporting.
Diagnostic immunology / allergy
Using autoantibody patterns in autoimmune disease, multiplex allergen-specific IgE testing and cytokine profiles, we study clinical phenotype classification and the optimization of testing algorithms.
Laboratory quality / diagnostic stewardship
Through internal and external quality control data, consistency of result reporting and communication between clinicians and the laboratory, we design systems that reduce unnecessary testing and support decisions.